A dose-finding phase II study of TAS-108
Phase of Trial: Phase II
Latest Information Update: 23 May 2016
At a glance
- Drugs SR 16234 (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 02 Oct 2012 New source identified and integrated.
- 01 Sep 2012 Results published in Cancer Science.
- 05 Nov 2010 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History